Cyproterone acetate: new advice to minimise risk of meningioma

Risk of meningioma increases with increasing cumulative dose; use is contraindicated in patients with previous or current meningioma for all indications and should only be considered for severe hypersexuality in adult men when other interventions are inappropriate.

Source:

Medicines and Healthcare products Regulatory Agency